Possu Huang Lab
@possuhuanglab.bsky.social
📤 461
📥 39
📝 23
Our lab uses experimental and computational methods to design de novo proteins | @Stanford
pinned post!
1/ In two back-to-back papers, we present our de novo TRACeR platform for targeting MHC-I and MHC-II antigens TRACeR for MHC-I:
go.nature.com/4gcLzn5
TRACeR for MHC-II:
go.nature.com/4gj5OQk
9 months ago
2
92
38
💻 Sampling and training code for Protpardelle-1c is now available:
github.com/ProteinDesig...
Feedback and requests are welcome!
add a skeleton here at some point
30 days ago
0
3
0
We have a new collection of protein structure generative models which we call Protpardelle-1c. It builds on the original Protpardelle and is tailored for conditional generation: motif scaffolding and binder generation.
about 1 month ago
1
22
6
SHAPES now published in Cell Systems!
add a skeleton here at some point
about 2 months ago
1
2
0
reposted by
Possu Huang Lab
Kevin K. Yang 楊凱筌
7 months ago
All-atom fixed backbone protein sequence design with FAMPNN
@richardshuai.bsky.social
Talal Widatalla
@possuhuanglab.bsky.social
@brianhie.bsky.social
www.biorxiv.org/content/10.1...
0
30
7
reposted by
Possu Huang Lab
Mohammed AlQuraishi
8 months ago
I'm organizing a Keystone symposium, along with Liz Kellogg and
@possuhuanglab.bsky.social
, on machine learning and macromolecules. Mar 23-26 in Keystone, Colorado. We have a great lineup and deadlines are coming up soon!
loading . . .
Machine Learning Applied to Macromolecular Structure and Function | Keystone Symposia
Join us at the Keystone Symposia on Machine Learning Applied to Macromolecular Structure and Function, March 2025, in Keystone, with field leaders!
https://www.keystonesymposia.org/conferences/conference-listing/meeting/X52025
0
43
18
reposted by
Possu Huang Lab
Kevin K. Yang 楊凱筌
8 months ago
A framework for evaluating how well generative models of protein structure match the distribution of natural structures.
@possuhuanglab.bsky.social
www.biorxiv.org/content/10.1...
0
43
10
New preprint from our group! We propose SHAPES, a set of metrics to quantify the distributional coverage of generative models of protein structures with embeddings at different structural hierarchies and quantify undersampling / extrapolation behaviors.
8 months ago
1
28
8
reposted by
Possu Huang Lab
Daniel Hoces
9 months ago
This is a clever way to use synthetic biology: taking a toxin that overactivate the immune system (superantigen), rationally modify its core components and transform it into a platform of immunotherapy agents. Congratulations to
@haotiandu.bsky.social
and
@possuhuanglab.bsky.social
on the 2 papers!
add a skeleton here at some point
1
6
2
reposted by
Possu Huang Lab
Carolyn Bertozzi
9 months ago
Checkout out these two bombshell papers from
@possuhuanglab.bsky.social
@stanfordmedicine.bsky.social
, computational design of antigen-specific binders to MHC-I or -II, with applications to next gen targeted therapeutics 🤯
add a skeleton here at some point
0
89
23
reposted by
Possu Huang Lab
Stanford Department of Bioengineering
9 months ago
Science in 60 Seconds: Haotian Du, PhD student with Possu Huang’s lab, explains her research on creating novel proteins that expands the possibilities for detecting more cancer types.
@possuhuanglab.bsky.social
@haotiandu.bsky.social
loading . . .
0
9
2
reposted by
Possu Huang Lab
Stanford Department of Bioengineering
9 months ago
Incredible work from BioE Professor’s Possu Huang Lab
@possuhuanglab.bsky.social
@haotiandu.bsky.social
- pioneering novel proteins with new structures and functions, unlocking new possibilities for detecting more cancer types. Congratulations!
add a skeleton here at some point
0
5
1
reposted by
Possu Huang Lab
9 months ago
Excited to share that TRACeR stories are out🙌
add a skeleton here at some point
0
5
3
reposted by
Possu Huang Lab
thetranscendedman
9 months ago
A new system, TRACeR-I, targets peptides on MHC I molecules with high precision, enabling specific tumor and virus cell killing. It powers CAR-T and BiTE therapies, showing potential to transform cancer and infectious disease treatment.
www.nature.com/articles/s41...
loading . . .
Targeting peptide antigens using a multiallelic MHC I-binding system - Nature Biotechnology
A protein platform rapidly develops peptide-focused major histocompatibility complex class I binders with high specificity.
https://www.nature.com/articles/s41587-024-02505-8
0
13
3
1/ In two back-to-back papers, we present our de novo TRACeR platform for targeting MHC-I and MHC-II antigens TRACeR for MHC-I:
go.nature.com/4gcLzn5
TRACeR for MHC-II:
go.nature.com/4gj5OQk
9 months ago
2
92
38
you reached the end!!
feeds!
log in